Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DraftKings Inc. f/k/a Diamond Eagle Acquisition Corp. (“DEAC”, “DraftKings”, or...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. (“Athira” or the “Company”) (NASDAQ: ATHA). Such investors are...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tarena International, Inc. (“Tarena” or the “Company”) (NASDAQ: TEDU). Such investors...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PureCycle Technologies, Inc. (“PureCycle” or the “Company”) (NASDAQ: PCT). Such...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN). Such investors are advised to...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- (GLOBENEWSWIRE) Pomerantz LLP is investigating claims on behalf of investors of RLX Technology Inc. (“RLX” or the “Company”) (NYSE: RLX). Such investors...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Churchill Capital Corporation IV (“Churchill” or the “Company”) (NYSE: CCIV). Such...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ubiquiti Inc. (“Ubiquiti” or the “Company”) (NYSE: UI). Such investors are advised to...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Rekor Systems, Inc. f/k/a Novume Solutions, Inc. (“Rekor” or the “Company”)...
-
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI). Such investors are...